首页> 外文OA文献 >Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

【2h】

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

We investigated the feasibility of serial dynamic contrast-enhanced computed tomography (DCE-CT) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) receiving anti-angiogenic (sorafenib) and anti-EGFR (erlotinib) treatment, and correlated tumour blood flow (BF) with treatment outcome.

机译：我们调查了在接受抗血管生成（索拉非尼）和抗EGFR（厄洛替尼）治疗的晚期/转移性非小细胞肺癌（NSCLC）患者中进行系列动态对比增强计算机断层扫描（DCE-CT）的可行性，并进行了相关性分析肿瘤血流（BF）与治疗结果有关。

著录项

作者
Lind, Joline S. W; Meijerink, Martijn R; Dingemans, Anne-Marie C; van Kuijk, Cornelis; Ollers, Michel C; De Ruysscher, Dirk; Postmus, Pieter E; Smit, Egbert F;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [J] . Lind JS, Meijerink MR, Dingemans AM, European radiology . 2010,第12期

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？
2. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [J] . Joline S. W. Lind, Martijn R. Meijerink, Anne-Marie C. Dingemans, European Radiology . 2010,第12期

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？
3. Inter-reader reproducibility of dynamic contrast-enhanced magnetic resonance imaging in patients with non-small cell lung cancer treated with bevacizumab and erlotinib [J] . van den Boogaart Vivian E. M., de Lussanet Quido G., Houben Ruud M. A., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2016,第Null期

机译：动态对比增强磁共振成像在贝伐单抗和厄洛替尼治疗的非小细胞肺癌患者中的阅读器间再现性
4. IMPROVING PREDICTION OF SURVIVAL USING CT-BASED TUMOR CHARACTERISTICS IN PATIENTS TREATED FOR METASTATIC NON-SMALL CELL LUNG CANCER [C] . WALKER H. LAND JR., ALAN LITWIN, DAN MARGOLIS, Artificial Neural Networks in Engineering Conference . 2010

机译：基于CT基肿瘤特征改善对转移性非小细胞肺癌的患者的肿瘤特征预测
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [O] . Joline S. W. Lind, Martijn R. Meijerink, Anne-Marie C. Dingemans, -1

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？
7. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? [O] . Joline S. W. Lind, Martijn R. Meijerink, Anne-Marie C. Dingemans, 2010

机译：索拉非尼和厄洛替尼治疗非小细胞肺癌患者的动态对比增强CT：监测治疗的新方法？

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅